TIME

Wednesday, Oct 13, 2010 (Grand Hyatt Hotel, Nusa Dua Bali)

Thursday, October 14 (Grand Hyatt Hotel, Nusa Dua Bali)

Friday, October 15 (Grand Hyatt Hotel, Nusa Dua Bali)

Sarurday

October 16

Registration: 07.00 – 15.00

Registration:  07.00 – 13.00

Grand ball room 1

Grand ball room 1

Grand ball room 2

Tabanan room-level 2

Grand ball room 1

Grand ball room 2

Tabanan room level-2

07.00 – 08.00

Morning Tea and POSTER SESSION day 1

Morning Tea & POSTER SESSION day 2

08.00–09.20

1. Registration of the Pre-APSTH Congres Symposium & Educaton Program

2. Registration of the 6th APSTH Congress:

Wednesday, Thursday,

Friday

Education  Program  I (E I):“DIC “

1, Disseminated Intravascular Coagula tion (DIC) in Sepsis & Obstetric Cases (Hideo Wada, Japan)

2. Pro & Ciontra: Heparin Therapy in DIC: Is it worth or exagerated? *

Education Program II  (E II): “APS-1” 

1. New Concept of   APS  Diagnosis (Steven Krilis, Australia)

2, Pro & Contra:  Anti thrombotic agents or Intravenous Immuno globulin (IvIg) in APS?*

Education Program III (E III): “Thrombosis in Geriatrics”

1.Thrombosis in Geriatric Patients (Satoshi Fujii, Japan)

2. Pro & Contra: Oral Anticoagulants in Geriatric Patients: Is it indicated or contra indicated?”

Education Program IV  (E IV): “APS-2”

1, Scandalization of laboratory diagnosis of APS in Asia (Masahide Yamazaki, Japan)

2, Pro & Contra: Anti phospholipid antibodies (APA): ACA, Antiβ2GP1, LA only or  other APAs? * 

Education Program V   (E V)””Platelets”

1,  Platelet Biology        (Michael Berndt, Irlandia / Australia)

2, Pro & Contra:  Bleeding Time: Is it still useful  or replaced by Platelet Function Test (e.g PFA 100)? *

Platelet Aggregation Test for Diagnostic or Treatment Monitoring?

Education Program VI

(E VI): “HIT”

1. Heparin-Induced Thrombocytopenia(HIT) (Shigeki Myata,Japan)

2, Pro & Contra: Antico agulants in HIT: Any  replacement for UFH ?

TOUR

Of

BALI

For Inter

national delegates

09.20–10.40

Pre Congress Symposium: (INSTRUMENTATION LABORATORIES):

1. Giovanni Russi, USA
2. Heparin-Induced Thrombocytopenia (HIT) State of The Art in HIT Diagnostics Testing (Ismail Elalamy, France)
3. Giovanni Russi, USA
4. Current Guidelines for APS Diagnostics Testing and New Emerging APS Markers (Tatsuya Atsumi, Japan)
5. Giovanni Russi, USA
6. Clinical Challenges in APS (Chris Ward, Australia)

Symposium I (S I)

 “PNH and Thrombosis”

(ALEXION)

1.Presence of thrombosis in PNH (Lee Joong Wook, South Korea)

2. PNH in 286 South Korean patients

(Illene Witz, USA) 

Symposium II (S II)

“Anticoagulants”

(GLAXO-SMITH-KLINE)

1, The Role of Anticoagulants in Medical Patients (tba)

2, Anticoagulants in Fetal Loss Syndrome (tba)

3. VTE trials & new anticoagulants ( Huyen Tran, Australia)

Symposium III (S III)

(BAXTER)

Symposium X (S X )

“Arterial Thrombosis”

(ASTRA ZENECA)

1.Endothel  Dysfunction in Thrombosis &the Role of Stem Cell Therapy (A Harryanto Reksodiputro,  

Indonesia)

2.Lipids  in the Pathogenesis of Arterial

Thrombosis and the Role of Statins (Slamet Suyono,   Indonesia)

Symposium XI (S XI)

“New oral anti coagulant agents: From basic to clinical applications” (BAYER SCHERING PHARMA)

1. Pharmacological Aspects of New Oral Anticoagulants “

2, Thromboprophilaxis in cancer patients (Karmel Tambunan, Indonesia)

3, Thromboprophilaxis in Hypercoagulable State”

Symposium XII (S XII)

“Thrombosis in Cancer”

1.Pathogenesis of Thrombosis in Cancer:

(Lee Lai Heng, Singapore)

2. Deep vein thrombosis in cancers (K. W. Lee, South Korea)*

3. What and When Laboratory Tests are used in Cancers  (Rahayuningsih Setiabudy, Indonesia)

10.40–11.00

 Tea Break and POSTER SESSION day 1

Tea Break and POSTER SESSION day 2

11.00-11.30

Plenary Lecture I (PL I):

Plenary Lecture  III (PL III)

Arterial Thrombosis: Stem Cell Therapy in Coronary Artery Disease and End Stage Myocardial Diseases

(Teguh Santoso, Indonesia)

11.30–12.00

Plenary Lecture II (PL II):

New Anticoagulants in the Treatment of Venous Thromboembolism  (Harry R Buller, the Netherlands)

Plenary Lecture IV (PL IV): Arterial Thrombosis:

Stem Cell Therapy in Peripheral Artery Disease (PAD)

( Takayuki Asahara, Japan)

12.00–13.30

Lunch Symposium I (LS II) (Stago Laboratory)

 12.00 – 13.00: “New Insights in DIC Diagnosis”

Chairman: Hideo Wada (Japan)

Speaker: tba

13.00 – 13.30: Lunch and break

Lunch Symposium II (LS III)  (Sysmex, Japan)

12.00 – 13.00: “tba”

Chairperson: tba

Speaker: tba

13.00 – 13.30: Lunch and break

Lunch

Pre – APSTH Education Program

1, New aspects of Protein C and Protein S

(P H Reitsman, the Netherlands)

2. Cell-based coagulation
(Dougald Monroe, USA)

 3. Protease-activated receptor
(Shaun Coughlin,USA)

4. Diagnosis and Treatment of  VTE

(DVT & PE)

(Harry R Buller, the Netherlands)

5. Risk Factors and Prevention of Recurrent Venous Thrombo Embolism (VTE)

(Jacqueline Conrad, France) 

         Free Time

13.30–14.50

Symposium IV (S IV)

 “Hemophilia Updates”

(DIPA PHARMA LAB)

1, Genetic approach to hemophilia therapy

(Tsuka Ohmori, Japan)

2.Anti  Hemophilic Agents (Midori Shima, Japan)

3.Plasma Factor VIII Relative Advantages than Recombinant

(tba)*

Symposium V (S V)

“Thrombosis in Women”

(SANOFI-AVENTIS)

1.Fetall Loss Syndrome in Indonesia (Julianto Wicaksonio,  (Indonesia)

2. Thrombosis in Pregnancy.Management of Post Partum Thrombosis (Claire McClintock, Australia)

3. Thromboproylaxis in Women with Fetall Loss Syndrome *

Symposium VI (S VI)

Hemostasis in  Asia Pacific Region (1):

1, Biology of snake venoms (Manjunatha R Kini, Singapore)

2, Coagulopathy related to snake venoms (Lisa Lincz, Australia)

3, Recombinant fibrinogenase from Agkistrodon acutus venom (Guangmei Yan, China)*

Symposium XIII (SXIII)“Antithrombotic Agents”

1, Pharmacogeneticsm of warfarin  (Yin Tong, China)*

2, Pharmacogenetics of clopidogrel (Kazzuo Umemura, Japan)

3,  New comers in antiplatelet agent           (Yukio Ozaki, Japan)

SymposiumXIV (S XIV)

 (BMS)

tba

Symposium XV(S XV)

“Thormbosis in Pe diatrics & Thalassemias”

1. Thrombsosi in Pediatrics (Djajadiman Gatot, Indonesia)”

2,Thrombosis  in Post-Splenectomized Thalassemias

(Vichai Aticharkatan, Thailand)*

3.Microparticles/vesicles in thalassemias  (Kovit Pattanapanyasat, Thailand)

14.50–16.10

Symposium VII (S VII)

“Chronic ITP”

1, “New aspects of ITP pathogenesis” (Prof Dr Masataka Kuwana, Japan)

2. “Circulating dendritic subsets & regulatory T cells in adult patients with Chronic ITP” (Ling Y, China)*

3. tba

 SymposiumVIII(S VIII)

“In-vitro and In-vivo Imaging of Thrombus Formation Process Under Blood Flow”

1. In-vivo Imaging of Platelet Thrombus Formation (Tetsumei Urano, Japan)

2. Computer Simulation (Shinya Goto, Japan)

3. Thrombus Formation as Assessed with Flow System (Shaun Jackson, Australia)

Symposium IX (S IX)

“ Hemostasis in Asia-Pacific Region (2)”

1.Coagulopathy in Malaria(Pantep

Angchaisuksiri, Thailand)

2. Genetic Disorders Related to Coagulopathy Prevalent in the Far East

(Tetsuhito Kojima, Japan)

3, Hemophilia in Cambodia (Robyn Devenish, Cambodia)

Symposium XVI(S AXVI)“ Liver and GIT Thrombosis & Bleeding”

(GRAHA PUTRA ABADI)

1, Hemostasis Abnormalities in Liver Diseases ( Karmel L Tambunan , Indonesia)

2, tba

3, tba

Symposium XVII (S XVII)

“Recent Progress of ADMTS13 in TTP”

1.Structure Function of ADAMTS13 (Dr Koichi Kokame, Japan)

2.Functional Property of ADAM13 Under Flow( Mitsuhiko Sugimoto, Japan)

3. Pathogenesis of Thrombotic Microangiopathy                (Masanori Matsumoto, Japan)

Symposium XVIII(S XVIII): “Antibody Against Platelet and Endothelial Cells”

1, Immune thrombo cytopenia caused by allo-&auto-antibodies

(Urich Sachs, Germany)

2, Cross-recative antibodies (e.g. anti=NS1 in dengue cases) (Sentot Santoso,Germany)

3, Drug dependent antibodies: tba

16.10-17.20

Free Oral Presentation I

(FOP I)

Free Oral Presentation II    (FOP II)

Free Oral Presentation III   (FOP III)

Selected  Oral Presentation I (SOP I)

 1.Cerebral Arterial Thrombosis  ( Teguh Ranakusuma,Indonesia)

2.Cerebral Venous Thrombosis (Freddy Sitorus,Indonesia)

3. Retinal Thrombosis  (Rumita Salim/  Andi Victor,Indonesia)

4. tba

Selected   Oral Presentation II (SOP II)

1.Thrombosis in Leukemias (Lugyanti Sukrisman ,Indonesia)

2. Hemostasis in Dengue Hemorrhagic Fever(DHF): Suharti,Indonesia)

3. MAIPA in DHF with  Thrombocytopenia: Andika R,Indonesia

4. tba

Seleted Oral Presentation III (SOP III)

1.Thrombosis in Orthopedics ( Andri Lubis,Indonesia)

2. Sudden Deafness (Yenny  Basaruddin, Indonesia)

3.Ultrasound in PAD (Ismoyo Sunu,Indonesia)

4. tba

17.20–18.00

Tea Break and POSTER SESSION  day 1

Tea Break and POSTER SESSION day 2

18.00–18.30

Free Time

Free Time

18.30 – 18.50

18.50 - 19.35

19.35 – 19.50

1. “Opening Ceremony”

= Welcome Speech  (Karmel L Tambunan, Indonesia)

= Opening Speech  (Hatem Salem, Australia)

2. “Special Lecture”

= Thrombomodulin: From Basic Science to Clinical Application

( Koji Suzuki , Japan)

3, Welcome Dinner

18.30 – 19.15: Evening Symposium I

19.15 – 20.00: Evening Symposium II 

20.00 – 21.30: Dinner

20.30 – 21.30: APSTH Business Meeting

21.30 – 21.45: Presentation of the 7th Congress of APSTH (Australia)

18.30 – 20.30: Dinner Presentations: ”VTE (DVT/PE) in Asia Pacific Region”: Report on VTE Registry & Problems in D/,Th/ & Prophylaxis Awareness in:  Australia, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Mongolia, the Philipines, Singapore, Sri Langka, Taiwan, Thailand, Vietnam, and New Caledonia

Each country is represented by 1 presentation @ 8 minutes (6 minutes: presentation and 2 minutes:  Q&A)

07.00

Registration

Chairperson: Karmel L. Tambunan (Indonesia)

08.00 – 08.15

Welcome and Opening Remarks (tba)

08.15 – 08.45

Instrumentation Laboratory Innovation

Giovanni Russi (USA)

08.45 - 09.30

Heparin-Induced Thrombocytopenia (HIT) State of the Art in HIT Diagnostic Testing and Diagnosis

Ismail Elalamy (France)

09.30 – 09.50

Developments in HIT Testing

Giovanni Russi (USA)

09.50 – 10.00

Coffee Break

10.00 - 10.45

Current Guidelines for APS Diagnostics Testing and New Emerging APS Markers

Tatsuya Atsumi (Japan)

10.45 - 11.30

Clinical Challenges in APS

Chris Ward (Australia)

11.30 - 11.50

The HemosIL Solution for APS Testing

Giovanni Russi (USA)

11.50 – 12.00

Closing Remarks (tba)

12.00

Lunch

PRE-APSTH EDUCATION PROGRAM (PAEP)

12.00 – 13.00

Registration for  Pre-APSTH EDUCATION PROGRAM (PAEP)

13.00 – 15.15

Session 1:

Chairperson: tba

13.00 – 13.45

13.45 – 14.30

14.30 – 15.15

(Presentation  30’ + Q&A 15’)

1. New aspects of Protein C and Protein S
(P H Reitsman, the Netherland)
2. Cell-based coagulation
(Dougald Monroe, USA)
3. Protease-activated receptor
(Shaun Coughlin,USA)

15.15 – 15.30

Tea break

15.30 – 17.00

Session 2:

Chairperson: tba

15.30 – 16.15

16.15 – 17.00

(Presentation  30’ + Q&A 15’)

1. Diagnosis and Treatment of  VTE (DVT and PE)

(Harry R Buller, the Netherland)

2. Risk Factors and Prevention of Recurrent Venous Thrombo Embolism (VTE)

 (Jacqueline Conard, France) 

SPECIAL  SYMPOSIUM  for National Participants

(Bangli 1-2  Room, Grand Hyatt, Nusa Dua, Bali)

07.00

Registration for Special Symposium for National Participants

07.15 – 08.05

Session I (SS 1):  Laboratory and Radio Imaging Diagnosis of Thrombosis

Chairperson :  Ketut Suega

07.15 – 07.40

07.40 – 08.05

(Presentation 20’ + Q & A 5’)

1. Platelet aggregation and Coagulation tests (including INR and D-dimer): Techniques/methods, standardization and how to expertise and to use the results in clinic

(Rahayuningsih Setyabudi)

1. Ultrasound and Radioimaging  in Diagnosing Venous & Arterial  Thrombosis (Armen Abdullah/Dr Jacub Pandelaki)                                                                                                                                                                                                 

08.05 – 10.10

Session 2 (SS 2): Acute & Chronic Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE),   Acute & Chronic Limb Ischemia, and Surgical Measurements ,  Stratifications of Risk Factors and laboratory Parameters

Chairperson: Iman Supandiman

08.05 – 08.30

08.30 – 08.55

08.55 – 09.20

09.20 – 09.45  

09.45 – 10.10

(Presentation 20’ + Q &A 5’)

1. DVT & PE: Pathogenesis, Diagnosis, Management of Acute & Chronic DVT (Post Thrombotic/Phlebitic Syndrome=PPS/PTS) & PE

( Karmel L Tambunan)                                                                     

 2. Acute & Chronic Limb Ischemia:Pathogenesis, Diagnosis and Management (Djumhana Atmakusuma)

 3. Surgical Measurement in  Acute&Chronic DVT (PPS/PTS) and Acute Limb Ischemia (Murnizal Dachlan) 

 4. Assessment & Stratification of DVT/VTE Risk Factors   (Medical and Surgical Risk Factors) (Aru Sudoyo)

5. Laboratory Parameters to Monitor the Efficacy and Safety of Anti-thrombotic Agents (Shuffri Effendi)

10.10 – 10.40

Tea  Break

10.40 – 13.10

Move to Plenary Lecture and Lunch Symposia (Grand Ball Room)

13.00 – 14.40

 Session 3 (SS 3): Antithrombotic Therapy in DVT, PE, and PAD

and Laboratory Parameters to Monitor the Efficacy and Safety. Chairperson: I Made Bakta

13.00 – 13.25

13.25 – 13.50

13.50 – 14.15

14.15 – 14.40

(Presentation 20’+ Q&A 5’)

1.  Anti Platelet Aggregation Agents

( C Suharti)                                                                              

2. Conventional  Oral  Anticoagulants

(A Harryanto Reksodiputro)                                                                                                                                                  

3.  New Oral Anticoagulants

( Lugyanti Sukrisman)

4. Parenteral Anticoagulants & Fibrinolytic Agents                                                                                 

(Cosphiadi Irawan)

End of symposium